CST3 and chronic kidney disease: Furthermore, cystatin C exhibits enhanced prognosticaccuracy for cardiovascular morbidity and mortality, especially in patients withchronic kidney disease (CKD) [11], diabetes mellitus [12], atrial fibrillation[13, 14], and ACS [15, 16].